Preliminary indications into South Sudan's recent viral hemorrhagic fever outbreak suggest that Rift Valley fever (RVF) may be the cause, the World Health Organization (WHO) Regional Office for Africa said in its latest outbreak and health emergencies update.
A growing number of vaccine makers are expressing concerns about their ability to quickly develop new vaccine candidates against emerging disease threat, such as Zika and Ebola viruses, Stat reported today, based on interviews with pharmaceutical executives, government officials, and infectious disease experts.
About 11% of a population sampled in the Democratic Republic of the Congo (DRC) had Zaire Ebola virus (EBOV) immunoglobulin G antibodies, providing serological evidence of Ebola prevalence in populations not currently experiencing an Ebola outbreak.
Yesterday and today the Saudi Arabian Ministry of Health (MOH) announced four new cases of MERS-CoV in different cities across the country, including one involving a health worker.
Survivors of the first reported outbreak of Ebola still harbor detectable antibodies to the virus 40 years later, and some of those antibodies can still neutralize live virus, researchers reported today in the Journal of Infectious Diseases.
Health officials in Hildago County on Dec 7 reported three recent Zika cases, one of which appears to have been transmitted locally by mosquitoes, the Texas Department of State Health Services (TDSHS) said yesterday in a statement.
Boston University's National Emerging Infectious Disease Laboratories (NEIDL) received final approval from the Boston Public Health Commission to conduct biosafety level 4 (BSL-4) research, clearing the final hurdle to begin work on some of the world's most lethal pathogens, such as Ebola and Marburg virus, BU Today, the campus newspaper, reported.
China has detected two new human avian influenza cases, one involving an adult sickened by H7N9 and the other a young child infected with H9N2, according to government reports in the region.
Analysis of blood samples provides clues about how the disease unfolds and which patients are more likely to die.
Tests on a traditional healer in Kenya who was a contact of one of the lab-confirmed Uganda Marburg patients has tested negative, and other high-risk contacts in Kenya have completed their 21-day monitoring periods, with no other illnesses detected, the World Health Organization (WHO) said yesterday.
